Michael R. Waters

3.3k total citations
41 papers, 674 citations indexed

About

Michael R. Waters is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael R. Waters has authored 41 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael R. Waters's work include Advanced Radiotherapy Techniques (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Michael R. Waters is often cited by papers focused on Advanced Radiotherapy Techniques (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Michael R. Waters collaborates with scholars based in United States, United Kingdom and Japan. Michael R. Waters's co-authors include Tomasz Kordula, Sarah Spiegel, Yan Zhang, Michael O. Idowu, Esraa Mohamed, Kai Jing, Guoyan Xu, Yibao Ma, Xianjun Fang and Huanjie Shao and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Michael R. Waters

40 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael R. Waters United States 15 324 139 134 123 64 41 674
Petra Ovesná Czechia 16 385 1.2× 88 0.6× 79 0.6× 82 0.7× 49 0.8× 77 838
Jessica K. Booker United States 13 304 0.9× 167 1.2× 179 1.3× 114 0.9× 68 1.1× 25 850
Sarah Stephenson Australia 14 259 0.8× 63 0.5× 186 1.4× 131 1.1× 53 0.8× 38 769
Jasmine Plummer United States 14 381 1.2× 83 0.6× 117 0.9× 89 0.7× 52 0.8× 25 918
C. Alexander Valencia United States 15 368 1.1× 103 0.7× 94 0.7× 124 1.0× 27 0.4× 34 725
Justine Guégan France 12 353 1.1× 136 1.0× 71 0.5× 71 0.6× 141 2.2× 23 627
Kai Yu United States 16 671 2.1× 228 1.6× 183 1.4× 182 1.5× 131 2.0× 42 1.2k
Bożena Szymańska Poland 15 334 1.0× 243 1.7× 75 0.6× 180 1.5× 40 0.6× 47 722
Zhaohao Huang China 15 373 1.2× 229 1.6× 61 0.5× 283 2.3× 48 0.8× 35 876

Countries citing papers authored by Michael R. Waters

Since Specialization
Citations

This map shows the geographic impact of Michael R. Waters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Waters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Waters more than expected).

Fields of papers citing papers by Michael R. Waters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Waters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Waters. The network helps show where Michael R. Waters may publish in the future.

Co-authorship network of co-authors of Michael R. Waters

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Waters. A scholar is included among the top collaborators of Michael R. Waters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Waters. Michael R. Waters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kelsen, Steven G., Marcus Maurer, Michael R. Waters, et al.. (2025). Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review. Respiratory Research. 26(1). 302–302.
3.
Waters, Michael R., Matthew Inkman, Roman O. Kowalchuk, et al.. (2024). GAiN: An integrative tool utilizing generative adversarial neural networks for augmented gene expression analysis. Patterns. 5(2). 100910–100910. 4 indexed citations
4.
Waters, Michael R., Matthew Inkman, J. Contreras, et al.. (2023). Genomic Characterization of Cervical Tumors Driven by Rare High-Risk HPV Subtypes Utilizing a Deep Learning Framework. International Journal of Radiation Oncology*Biology*Physics. 117(2). S131–S131. 1 indexed citations
5.
Tyc, Katarzyna M., A. Rory McQuiston, Amy L. Olex, et al.. (2023). Yin Yang 1 controls cerebellar astrocyte maturation. Glia. 71(10). 2437–2455. 5 indexed citations
6.
Waters, Michael R., Alex Price, Eric Laugeman, et al.. (2023). CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer. Clinical and Translational Radiation Oncology. 44. 100693–100693. 12 indexed citations
7.
Andruska, Neal, Michael R. Waters, Benjamin W. Fischer‐Valuck, et al.. (2023). Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?. Clinical Genitourinary Cancer. 21(6). 653–659.e1. 2 indexed citations
8.
Zhang, Fengyu & Michael R. Waters. (2021). Correction: Pathogen Genomics and Host Cellular Susceptibility Factors of COVID-19. 1 indexed citations
9.
Zhang, Jin, Matthew Inkman, Michael R. Waters, et al.. (2021). Integrating imaging and RNA-seq improves outcome prediction in cervical cancer. Journal of Clinical Investigation. 131(5). 13 indexed citations
10.
11.
Waters, Michael R., et al.. (2019). Long-term sleep disturbance and prescription sleep aid use among cancer survivors in the United States. Supportive Care in Cancer. 28(2). 551–560. 39 indexed citations
12.
Yamada, Akimitsu, Masayuki Nagahashi, Tomoyoshi Aoyagi, et al.. (2018). ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. Molecular Cancer Research. 16(6). 1059–1070. 61 indexed citations
13.
Farrar, Jared S., Jeremy A. Meier, Moonjung Hyun, et al.. (2018). STAT3 suppresses Wnt/β-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine. 111. 434–444. 16 indexed citations
14.
Elsayed, Zeinab, Michael R. Waters, Tana Blevins, et al.. (2017). BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Oncotarget. 8(38). 64344–64357. 27 indexed citations
15.
Yester, Jessie, Lauren Bryan, Michael R. Waters, et al.. (2015). Sphingosine‐1‐phosphate inhibits IL‐1‐induced expression of C‐C motif ligand 5 via c‐Fos‐dependent suppression of IFN‐β amplification loop. The FASEB Journal. 29(12). 4853–4865. 17 indexed citations
16.
Waters, Michael R., Casey M. Rebholz, Bradford J. Wood, et al.. (2012). Second to fourth digit ratio and prostate cancer severity. Prostate Cancer and Prostatic Diseases. 16(1). 107–110. 20 indexed citations
17.
Fox, J. Christian, et al.. (2010). Effect of a Medical Student Emergency Ultrasound Clerkship on Number of Emergency Department Ultrasounds. SHILAP Revista de lepidopterología. 8 indexed citations
18.
Fox, J. Christian, et al.. (2010). Effect of a medical student emergency ultrasound clerkship on number of emergency department ultrasounds.. PubMed. 11(1). 31–4. 7 indexed citations
19.
Waters, Michael R.. (1993). Poisoning and Drug Overdose. Emergency Medicine Journal. 10(3). 258–259. 10 indexed citations
20.
Waters, Michael R., et al.. (1986). The Effect of Body Fat Content on Pharmacokinetics of Cyclosporin A. Clinical Science. 71(s15). 2P–2P. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Ovesná Breakdown of academic impact, for papers by Jessica K. Booker Breakdown of academic impact, for papers by Sarah Stephenson Breakdown of academic impact, for papers by Jasmine Plummer Breakdown of academic impact, for papers by C. Alexander Valencia Breakdown of academic impact, for papers by Justine Guégan Breakdown of academic impact, for papers by Kai Yu Breakdown of academic impact, for papers by Bożena Szymańska Breakdown of academic impact, for papers by Zhaohao Huang
Rankless by CCL
2026